DUBLIN, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
Trinity Biotech ( ($TRIB) ) just unveiled an update. On December 15, 2025, Trinity Biotech announced that it has secured regulatory clearances in ...
Company advances its mission to deliver next-generation diabetes management solutions and expand global market penetration Next-generation column technology enhances efficiency, expands recurring ...
Next-generation column technology enhances efficiency, expands recurring revenue potential, and strengthens Trinity Biotech's competitive position in the $2B+ HbA1c market DUBLIN, Dec. 15, 2025 (GLOBE ...